The financial facts do indeed tell a lousy story. The value of ENZC has always been intellectual property and the potential to deliver much safer/effective medical treatments. Delivery potential remains just that — potential. Execution updates have typically focused on “what we are planning to do”. There is typically very little commentary on what has been accomplished. So, we’re back to intellectual property primarily.
News 
Market Data 
Discover 
AI
